TABLE 4.
The enriched KEGG pathway and the related genes.
Pathway | Genes | Fold enrichment | p Value |
---|---|---|---|
Alzheimer’s disease | BACE1, GSK3B, APP, MME, IL1B, PSEN2, MAPT, GRIN2B, SNCA | 11.52 | 0.0000 |
Neuroactive ligand-receptor interaction | GABRA1, CHRM1, GLRB, PTAFR, HTR1A, HTR2A, GRIN2B, LTB4R | 6.21 | 0.0002 |
PI3K-Akt signaling pathway | ITGB1, IL4, GSK3B, IL6, CHRM1, NOS3, MET, VEGFA | 4.98 | 0.0007 |
Pathways in cancer | ITGB1, RET, PRKCG, GSK3B, IL6, HIF1A, MET, VEGFA | 4.38 | 0.0015 |
Proteoglycans in cancer | ITGB1, PRKCG, PLAU, HIF1A, MET, VEGFA | 6.45 | 0.0018 |
Hematopoietic cell lineage | IL4, IL6, MME, IL1B, ANPEP | 12.35 | 0.0006 |
HIF-1 signaling pathway | PRKCG, IL6, NOS3, HIF1A, VEGFA | 11.20 | 0.0008 |
Calcium signaling pathway | PRKCG, CHRM1, NOS3, PTAFR, HTR2A | 6.00 | 0.0081 |
Focal adhesion | ITGB1, PRKCG, GSK3B, MET, VEGFA | 5.22 | 0.0130 |
Rap1 signaling pathway | ITGB1, PRKCG, GRIN2B, MET, VEGFA | 5.12 | 0.0139 |